SCHEMBL3899355

SCHEMBL3899355

N#CN(C(=O)C1(OC(=O)NCc2ccccc2)CCCCC1)C1CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.42
EPHX1 P07099 1/20 0.42
RAB9A P51151 3/20 0.39
NPC1 O15118 2/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALDH1A1 P00352 3/20 0.39
USP2 O75604 1/20 0.39
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSS P25774 1/20 0.39
CCNK O75909 1/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
CDK12 Q9NYV4 1/20 0.38
BCHE P06276 2/20 0.37
MCL1 Q07820 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3898232 0.84 CTSB (0.43) HPGDEPHX1CTSLCTSBCTSS
SCHEMBL6567357 0.79 EPHX2 (0.40) HPGDEPHX1LMNAALDH1A1CTSL
SCHEMBL6567332 0.78 CTSB (0.40) HPGDEPHX1RAB9ANPC1MAPT
SCHEMBL7431174 0.77 LMNA (0.37) HPGDEPHX1RAB9ANPC1LMNA
SCHEMBL3898239 0.77 CTSL (0.57) HPGDEPHX1CTSLCTSBCTSS
SCHEMBL7434373 0.75 CTSB (0.40) HPGDEPHX1CTSLCTSBCTSS
SCHEMBL3893533 0.75 CTSL (0.48) HPGDEPHX1CTSLCTSBCTSS
SCHEMBL3908088 0.74 CTSB (0.41) HPGDEPHX1ALDH1A1CTSLCTSB
SCHEMBL6567042 0.74 CTSS (0.35) HPGDEPHX1LMNACTSLCTSB
SCHEMBL3908091 0.73 CTSS (0.41) HPGDCTSLCTSBCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002100849-A2 NOVEL NITRILES USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2002-12-19 WO claimed
EP-1399431-B1 NOVEL NITRILES USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMA (US) 2009-02-18 EP disclosed
WO-2002100849-A2 NOVEL NITRILES USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed